Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2026-08-20 17:25:38 ET · period of report 2026-08-18 · accession 0001140361-26-033913 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-20 17:25 | 2026-08-18 | RCKT | Shah Gaurav | CEO | S - Sale | $3.38 | -2,293 | 1.06M | -0.2% | -$7,753 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-18 | S | D | 2,293 | $3.38 | 1,056,594 | D | — | — | (F1) Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. (F2) The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs. (F1) Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. |